Fig. 3From: Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [11C]CB184, in healthy human volunteersComparison of the V T for typical subjects and an atypical subject. Data for typical subjects represent the mean with the 95% confidential interval for four subjectsBack to article page